Nanoparticles của phức hợp ZnO/Berberine chống lại COVID-19 và nhiễm khuẩn đồng mắc đường hô hấp cũng như loại bỏ độc tính của hydroxychloroquine
Tóm tắt
Từ khóa
#COVID-19 #Berberine #ZnO nanoparticles #phức hợp ZnO/BER #thuốc kháng virus #độc tính HCQTài liệu tham khảo
Agency EM (2020) COVID-19: chloroquine and اydroxychloroquine only be used in clinical trials or emergency use programmes [Online]. Available: https://www.ema.europa.eu/en/news/covid-19-chloroquine-hydroxychloroquine-only-be-used-clinical-trials-emergency-use-programmes. Accessed 1 Apr 2020
Barnabas RV, Brown ER, Bershteyn A, Stankiewicz Karita HC, Johnston C, Thorpe LE, Kottkamp A, Neuzil KM, Laufer MK, Deming M, Paasche-Orlow MK, Kissinger PJ, Luk A, Paolino K, Landovitz RJ, Hoffman R, Schaafsma TT, Krows ML, Thomas KK, Morrison S, Haugen HS, Kidoguchi L, Wener M, Greninger AL, Huang M-L, Jerome KR, Wald A, Celum C, Chu HY, Baeten JM (2020) Hydroxychloroquine as postexposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 infection. Ann Internal Med.
El-Zahaby SA, Aboughaly MH, Abdelbary GA, El-Gazayerly ON (2016) Development of a novel solid self-nano-emulsifying osmotically controlled system of a centrally acting drug: preparation and in-vitro evaluation. Inventi Impact NDDS 2016:35–49
Ernst E, Rose M, Lee R (1984) Modification of transoperative changes in blood fluidity by hydroxychloroquine: a possible explanation for the drug’s antithrombotic effect. Pharmatherapeutica 4:48–52
Ghareeb AE, Moawed FSM, Ghareeb DA, Kandil EI (2018) Potential prophylactic effect of berberine against rat colon carcinoma induce by 1,2-Dimethyl Hydrazine. Asian Pac J Cancer Prev 19:1685–1690
Pingali S, Donahue J, Payton-Stewart F (2014) Weak C-H···X (X = O, N) hydrogen bonds in the crystal structure of dihydroberberine. Acta crystallographica Section c Struct Chem 70:388–391
Who. 2021. Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19 [Online]. Available: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-combination-treatment-covid-19. Accessed 12 March 2021.
Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F (2020) Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery 6:14